Study of SPG302 in Adults With Schizophrenia
Clinical trial NCT06442462 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06442462
- Sponsor
- Spinogenix
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-03-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.